Safety of Artemisinin-Based Combination Therapies in Nigeria: A Cohort Event Monitoring Study

被引:0
|
作者
Peter Usman Bassi
Adeline I. Osakwe
Ambrose Isah
Comfort Suku
Musa Kalat
Iliya Jalo
Robinson Daniel Wammanda
Chika Ugochukwu
Olubukula Adesina
Eno Etim Nyong
Frank Osungwu
Shanti Pal
Sylvester Chigozie Nwoasu
Magnus Wallberg
David Coulter
机构
[1] University of Maiduguri,Department of Clinical Pharmacology and Therapeutics, College of Medical Sciences, PMB1069
[2] National Pharmacovigilance Centre NAFDAC Abuja,Clinical Pharmacology Unit
[3] FCT,Department of Paediatrics
[4] University of Benin Teaching Hospital,Department of Paediatrics
[5] Federal Medical Centre,Department of Paediatrics
[6] Ahmadu Bello University Teaching Hospital,Department of Obstetrics and Gynaecology
[7] Nnamdi Azikwe University Teaching Hospital,Department of Paediatrics
[8] University College Hospital,WHO Department of Essential Medicine and Health Products
[9] University of Uyo Teaching Hospital,Department of Mathematics and Statistics
[10] MOPD Clinic,undefined
[11] Nigerian Institutes for Pharmaceutical Research and Development,undefined
[12] Idishin Abuja–FCT,undefined
[13] WHO,undefined
[14] University of Maiduguri,undefined
[15] Uppsala Monitoring Centre,undefined
[16] WHO Collaborating Centre for International Drug Monitoring,undefined
[17] Private Consultant in Pharmacovigilance and Pharmacoepidemiology,undefined
来源
Drug Safety | 2013年 / 36卷
关键词
Malaria; Artemisinin; Artesunate; Uncomplicated Malaria; Artemether;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:747 / 756
页数:9
相关论文
共 50 条
  • [31] Monitoring the Efficacy and Safety of Artemisinin-Based Combination Therapies: A Review and Network Meta-analysis of Antimalarial Therapeutic Efficacy Trials in Cameroon
    Youdom, Solange Whegang
    Chiabi, Andreas
    Basco, Leonardo K.
    DRUGS IN R&D, 2019, 19 (01) : 1 - 14
  • [32] Monitoring the Efficacy and Safety of Artemisinin-Based Combination Therapies: A Review and Network Meta-analysis of Antimalarial Therapeutic Efficacy Trials in Cameroon
    Solange Whegang Youdom
    Andreas Chiabi
    Leonardo K. Basco
    Drugs in R&D, 2019, 19 : 1 - 14
  • [33] Progress toward elimination of malaria in Nigeria: Uptake of artemisinin-based combination therapies for the treatment of malaria in households in Benin City
    Akoria, Obehi Aituaje
    Arhuidese, Isibor James
    ANNALS OF AFRICAN MEDICINE, 2014, 13 (03) : 104 - 113
  • [34] Artemisinin resistance or artemisinin-based combination therapy resistance?
    Wongsrichanalai, Chansuda
    LANCET INFECTIOUS DISEASES, 2013, 13 (02): : 114 - 115
  • [35] A major transition in malaria treatment: The adoption and deployment of artemisinin-based combination therapies
    Bosman, Andrea
    Mendis, Kamini N.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (06): : 193 - 197
  • [36] COMMUNITY EFFECTIVENESS OF ARTEMISININ-BASED COMBINATION THERAPY FOR MALARIA IN RURAL SOUTHWESTERN NIGERIA
    Yusuf, O. B.
    Falade, C. O.
    Ajayi, I. O.
    Gbotosho, G. O.
    Happi, T. C.
    Pagnoni, F.
    INTERNATIONAL QUARTERLY OF COMMUNITY HEALTH EDUCATION, 2009, 29 (01) : 45 - 56
  • [37] Ethical considerations in deploying triple artemisinin-based combination therapies for malaria: An analysis of stakeholders' perspectives in Burkina Faso and Nigeria
    Tindana, Paulina
    Guissou, Rosemonde
    Bolarinwa, Oladimeji Akeem
    Tou, Fatoumata
    de Haan, Freek
    Dhorda, Mehul
    Dondorp, Arjen M.
    Amaratunga, Chanaki
    Mokuolu, Olugbenga Ayodeji
    Ouedraogo, Jean Bosco
    Cheah, Phaik Yeong
    PLOS ONE, 2022, 17 (09):
  • [38] Policy brief on improving access to artemisinin-based combination therapies for malaria in Cameroon
    Ongolo-Zogo, Pierre
    Bonono, Renee-Cecile
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2010, 26 (02) : 237 - 241
  • [39] Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies
    Justin M Cohen
    Inder Singh
    Megan E O'Brien
    Malaria Journal, 7
  • [40] Macro environment determinants affecting the availability of artemisinin-based combination therapies in Uganda
    Oluka Nagitta, Pross
    Mkansi, Marcia
    INTERNATIONAL JOURNAL OF PHARMACEUTICAL AND HEALTHCARE MARKETING, 2023, 17 (01) : 97 - 114